Meta-analysis of the comparative efficacy and safety of adjuvant treatment to levodopa in later Parkinson's disease.

Stowe, Rebecca; Ives, Natalie; Clarke, Carl E; Handley, Kelly; Furmston, Alexandra; Deane, Katherine; van Hilten, J J; Wheatley, Keith; Gray, Richard

Stowe, Rebecca; Ives, Natalie; Clarke, Carl E; Handley, Kelly; Furmston, Alexandra; Deane, Katherine; van Hilten, J J; Wheatley, Keith; Gray, Richard.

Affiliation

Stowe R; Birmingham Clinical Trials Unit, College of Medical & Dental Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom. r.l.harrison@bham.ac.uk

Mov Disord ; 26(4): 587-98, 2011 Mar.

Article in En | MEDLINE | ID: mdl-21370258

Subject(s)

Adjuvants, Pharmaceutic/therapeutic use; Antiparkinson Agents/therapeutic use; Levodopa/therapeutic use; Parkinson Disease/drug therapy; Clinical Trials as Topic; Disability Evaluation; Enzyme Inhibitors/therapeutic use; Humans; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Levodopa / Adjuvants, Pharmaceutic / Antiparkinson Agents Type of study: Clinical_trials / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Mov Disord Journal subject: NEUROLOGIA Year: 2011 Type: Article Affiliation country: United kingdom

Fulltext

XML

PubMed Links

Search on Google